![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 23, 20804-20811, June 7, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Trinity College Institute of Neuroscience, Department of
Physiology, Trinity College, Dublin 2, Ireland and
Received for publication, March 12, 2002, and in revised form, March 21, 2002
Exposure to irradiation leads to detrimental
changes in several cell types. In this study we assessed the changes
induced in hippocampus by exposure of rats to whole body irradiation; the findings reveal that irradiation leads to apoptotic cell death in
hippocampus, and as a consequence, long term potentiation in perforant
path-granule cell synapses is markedly impaired. The evidence is
consistent with the view that irradiation induced an increase in
reactive oxygen species and that this leads to stimulation of the
stress-activated protein kinase, JNK, and activation of the
transcription factor, c-Jun. Consequent upon activation of JNK, a
cascade of cell signaling events was stimulated that ultimately
resulted in apoptosis, as suggested by parallel increases in cytochrome
c translocation, caspase-3 activation, poly(ADP-ribose) polymerase cleavage, and terminal dUTP nick-end labeling staining. Treatment of rats with eicosapentaenoic acid inhibited the
irradiation-induced increase in reactive oxygen species production and
the subsequent cellular signaling events, suggesting that oxidative
stress triggered apoptotic cell death in the hippocampus of rats
exposed to irradiation. Significantly, when the compromise in cell
viability induced by irradiation was prevented by eicosapentaenoic
acid, long term potentiation was sustained in a manner similar to that
in the sham-treated control group.
It has been recognized for some time that neuronal tissue is
susceptible to oxidative stress because of its high oxygen consumption and modest antioxidant defenses (1). These features are coupled with a
high concentration of iron (2) and high concentrations of
polyunsaturated fatty acids, which are easily oxidized and known to
generate oxygen radicals following oxidation (3). Reactive oxygen
species (ROS),1 in particular
the hydroxyl radical, can lead to functional alterations in lipids,
proteins, and nucleic acids, and an accumulation of ROS is considered
to be one factor that contributes to neurodegenerative changes, for
example in Parkinson's disease (4) and Alzheimer's disease (5).
Indeed recent data from studies undertaken in this laboratory have
indicated that there is an increase in ROS accumulation in the
hippocampus prepared from aged, compared with young, rats and that this
is accompanied by an impairment in long term potentiation (LTP) in
perforant path-granule cell synapses (6). Further studies have revealed
that activities of two mitogen-activated protein (MAP) kinases, c-Jun
NH2-terminal kinase (JNK) and p38 MAP kinase, are increased
in vivo when ROS accumulation is increased, for example in
hippocampal tissue prepared from aged rats (7) or rats injected
intracerebroventricularly with the proinflammatory cytokine,
interleukin-1 An increase in ROS production occurs following irradiation (9), and
therefore, it is not surprising to find that at least some effects of
exposure of cells to ROS are mimicked by exposure of cells to ionizing
radiation. For example, exposure of guinea pigs to We have reported that age-related deficits in LTP and the accompanying
changes in IL-1 Animals--
In this experiment 24 male Wistar rats were divided
into four groups of 6. The animals were housed in groups of 6 in the
BioResources Unit, Trinity College, Dublin, Ireland, under a 12-h light
schedule, with the ambient temperature controlled between 22 and
23 °C. Food and water intake was measured daily for 1 week, and at
the end of this period, 12 rats were assigned to a group that was fed
on normal laboratory chow supplemented with ethyl EPA (2% v/w,
dissolved in corn oil; Laxdale Ltd., UK) for 4 weeks. The remaining 12 rats received control diet (laboratory chow to which only corn oil was
added). Rats were offered 100% of their average daily food intake so
that the full daily allowance of EPA would be ingested. Sufficient diet
was prepared for 2-3 days at a time. Food and water intake did not
vary between groups, and there was no significant difference in daily
food and water intake before and after dietary modifications were made.
Rats were maintained under veterinary supervision for the duration of
this experiment.
At the end of this 4-week period, half of rats were exposed to whole
body irradiation (10 gray at a rate of 10 gray/min; Nordion Gammacell
Cesium Irradiator). The remaining rats were sham-irradiated. Rats were
monitored for the 4 days following irradiation and were then assessed
for their ability to sustain LTP.
Induction of LTP in Perforant Path-Granule Cell Synapses in
Vivo--
LTP was induced as described previously (29). Rats were
anesthetized by intraperitoneal injection of urethane (1.5 g/kg) and
placed in a head holder in a stereotaxic frame. A window of skull was removed to allow placement of recording and stimulating electrodes in the molecular layer of the dentate gyrus (2.5 mm lateral
and 3.9 mm posterior to bregma) and perforant path, respectively (angular bundle, 4.4 mm lateral to lambda). The depth of the electrodes was adjusted to obtain maximal responses in the cell body region. Test
shocks at the rate of 1/30 s were delivered to the perforant path;
base-line recordings were allowed to stabilize for about 15 min, and
then electrophysiological recording commenced and continued for 10 min
before and 40 min after tetanic stimulation (3 trains of stimuli; 250 Hz for 200 ms; intertrain interval 30 s). At the end of the
electrophysiological recording period, rats were killed by
decapitation; the hippocampus was removed, dissected on ice, and
cross-chopped into slices (350 × 350 µm) using a McIlwain tissue chopper. The time taken to prepare slices from the time of death
was 2.5-3.5 min. All samples were frozen separately in 1 ml of Krebs
solution (composition of Krebs in mM: NaCl 136, KCl 2.54, KH2PO4 1.18, MgSO4·7H2O 1.18, NaHCO3 16, glucose 10, CaCl2 1.13) containing 10% dimethyl sulfoxide
as described previously (29, 33). For analysis, thawed slices of tissue
were rinsed 3 times in fresh Krebs buffer and homogenized in fresh
lysis buffer (20 mM HEPES (pH 7.4); 10 mM KCl;
1.5 mM MgCl2; 1 mM EGTA; 1 mM EDTA; 1 mM dithiothreitol; 0.1 mM phenylmethylsulfonyl fluoride; 2 µg/ml leupeptin; 2 µg/ml aprotinin; 200 mM sucrose), except in the case of
tissue that was used for analysis of ROS, which was homogenized in 40 mM Tris-HCl (pH 7.4).
Analysis of Reactive Oxygen Species--
The formation of
reactive oxygen species was assessed in the impure synaptosomal
preparation, P2, as described previously (34). The method
relies on oxidation of the non-fluorescent probe,
2',7'-dichlorofluorescin diacetate, by reactive oxygen species, to the
highly fluorescent 2',7-dichlorofluorescein. To assess reactive oxygen
species production, synaptosomes were prepared as described previously
(29, 33) from hippocampal slices obtained from Analysis of JNK Phosphorylation, c-Jun Phosphorylation, JIP-1
Expression, Cytochrome c Translocation, and PARP Cleavage--
JNK
phosphorylation, cytochrome c translocation, PARP cleavage,
c-Jun phosphorylation, and JIP-1 expression were analyzed in samples
prepared from hippocampal tissue using a method described previously
(35). In the case of JNK, PARP, c-Jun, and JIP tissue homogenates were
diluted to equalize for protein concentration, and aliquots (100 µl,
2 mg/ml) were added to 100 µl of sample buffer (Tris-HCl, 0.5 mM (pH 6.8); glycerol 20%; SDS, 2%;
The effects of H2O2 and VIP were also assessed
on the activity of JNK. Hippocampal slices were homogenized in either
Krebs solution or VIP (10 µM) and incubated for 20 min at
37 °C with O2 in Krebs solution in the presence or
absence of H2O2 (200 µM). The
analysis proceeded as described above.
Analysis of Caspase-3 Activity--
Cleavage of the caspase-3
substrate (Ac-DEVD-7-amino-4-trifluoromethylcoumarin peptide,
Alexis Corp.) to its fluorescent product was used as a measure of
caspase-3 activity. Slices of hippocampal tissue were washed,
homogenized in lysis buffer (400 µl; 25 mM HEPES, 5 mM MgCl2, 5 mM dithiothreitol, 5 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml pepstatin (pH 7.4)), incubated on ice for
20 min, analyzed for protein concentration, and diluted to equalize for
protein concentration. Homogenates (98 µl) were added to 2 µl of
caspase-3 substrate (final concentration 5 µM, from a
stock solution of 5 mM in incubation buffer; 100 mM HEPES, 5 mM dithiothreitol (pH 7.4)),
transferred to a 96-well plate, and incubated for 1 h at 37 °C.
Fluorescence was assessed (excitation, 390 nm; emission 510 nm), and
enzyme activity was calculated with reference to a standard curve of
7-amino-4-trifluoromethylcoumarin (0-10 µM)
concentration versus absorbance; values were therefore expressed as nmol of
7-amino-4-trifluoromethylcoumarin/mg of protein/min.
The effects of H2O2 and VIP were also assessed
on the activity of caspase-3. Hippocampal slices were homogenized in
either Krebs solution or VIP (10 µM) and incubated for 20 min at 37 °C with O2 in Krebs solution in the presence
or absence of H2O2 (200 µM). The
analysis of caspase-3 activity proceeded as described above.
Dissociation of Cells and Analysis of TUNEL
Staining--
Dissociated cells were prepared from slices of
hippocampus as described previously (36). Briefly, slices were
incubated for 45 min in HEPES-buffered Krebs solution (pH 7.4;
composition in mM: NaCl, 145; KCl, 5; MgCl2, 1;
CaCl2, 2; Mg2SO4, 1;
KH2PO4, 1; glucose, 10; HEPES, 30) containing
trypsin (1 mg/ml) and DNase (1600 units/liter) protease X (1 mg/ml),
protease XIV (1 mg/ml), and DNase (1600 units/liter). Washed slices
were resuspended in 750 µl of PBS, triturated with a fire-polished
Pasteur pipette, and passed through a nylon mesh filter to remove
tissue clumps. Aliquots (100 µl) of the cell suspension were spun
onto glass slides at 600 rpm for 2 min (Shandon Cytospin 3), and cells
were fixed in methanol and stored at room temperature for later use. Apoptotic cell death was assessed using the DeadEnd Colorimetric Apoptosis Detection System (Promega). The cytospun cells were fixed for
25 min with 4% paraformaldehyde, washed twice for 5 min in PBS,
permeabilized with proteinase K, and washed. Cells were immersed for 10 min in equilibration buffer and incubated at 37 °C for 60 min with
TDT mix, containing TdT enzyme (25 units/µl), biotinylated nucleotide
mix, and equilibration buffer. The reaction was terminated by
incubating the cells in sodium chloride/sodium citrate buffer for 15 min at room temperature. Cells were washed three times in PBS to remove
unincorporated biotinylated nucleotides, and endogenous peroxidases
were blocked by incubating in the presence of 0.3%
H2O2 for 5 min. Cells were washed, incubated
with streptavidin horseradish peroxidase (1:500 in PBS) for 30 min at
room temperature, and washed again, and staining was developed by
addition of the chromogene 3,3'-diaminobenzidine tetrahydrochloride and
H2O2 for 20 min. By using this procedure,
apoptotic nuclei were stained dark brown. Negative cells were
counter-stained with toluidine blue, dehydrated through alcohol to
xylene, and mounted in distyrene plasticizer in xylene and
viewed under ×40 magnification.
Statistical Analysis--
Data are expressed as the mean ± S.E. A one-way analysis of variance (ANOVA) was performed to determine
whether there were significant differences between conditions. When
this analysis indicated significance (at the 0.05 level), post hoc
Student's Newmann-Keuls test analysis was used to determine which
conditions were significantly different from each other.
Fig. 1 demonstrates that LTP was
impaired in rats that were exposed to irradiation; the mean percentage
change (± S.E.) in excitatory postsynaptic potential slope in
the 2 min immediately following tetanic stimulation (compared with that
in the 5 min immediately prior to stimulation) was 127.99% (± 3.61),
which was significantly decreased compared with the corresponding value in sham-irradiated rats, 148.18% (±7.31; p < 0.05;
ANOVA; n = 6 in both groups). The mean percentage
changes in the last 5 min of the experiment were 134.17 (±3.60) and
98.82% (±12.51) in sham-irradiated and irradiated rats, respectively
(p < 0.001; n = 6 in both groups). The
mean percentage changes in the 2 min immediately following tetanic
stimulation and in the last 5 min of the experiment were 155.83 (±6.23) and 120.45% (±1.14) in sham-irradiated rats that were
treated with EPA for 4 weeks prior to analysis of LTP; the corresponding values in irradiated rats that were treated with EPA were
146.22 (±5.01) and 119.38% (±1.16). Although irradiation resulted in
a significant attenuation of LTP (p < 0.001; ANOVA), the inhibitory effect of irradiation was reversed by treatment with EPA
so that there was a significant difference in the response to tetanic
stimulation in control-treated and EPA-treated irradiated rats
(p < 0.001; ANOVA). However, it should be noted that
the degree of LTP sustained by control-treated, sham-irradiated rats was greater than EPA-treated irradiated rats (p < 0.05; ANOVA).
Mean ROS accumulation was similar in control-treated and EPA-treated
sham-irradiated rats but was significantly enhanced in hippocampal
tissue prepared from irradiated rats compared with sham-irradiated rats
(Fig. 2a; p < 0.05; ANOVA). Treatment with EPA reversed the irradiation-induced
change, so that this value was similar to the values in tissue prepared
from sham-irradiated rats.
Neuroprotective Effect of Eicosapentaenoic Acid in
Hippocampus of Rats Exposed to
-Irradiation*
, and
Laxdale Ltd., Stirling, Scotland, United Kingdom
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(IL-1
) (8). Significantly, dietary manipulation
with
-3 fatty acids, which restored the ability of aged rats to
sustain LTP, reversed the age-related activation of JNK and p38, which
accompanied the deficit in LTP (7).
-irradiation is
associated with impaired LTP in CA1 slices (10-12), and
H2O2 has been shown to inhibit LTP in CA1 in
guinea pig slices (13). Similarly, LTP is diminished in dentate gyrus in vivo in rats which received H2O2
intracerebroventricularly (14) and in IL-1
-treated and aged rats (7,
15) in which an increase in hippocampal ROS accumulation has been
described. It has also been shown that the activities of both JNK and
p38 are increased by irradiation (16, 17) as well as by
H2O2 (7). Interestingly, it has been reported
that exposure of Jurkat T cells to
-irradiation led to increased JNK
activation (16), and its activation (but not activation of either p42
MAP kinase or p38) was correlated with apoptotic changes (18). Several reports have implicated the JNK pathway in apoptosis in a variety of
cell types (for example, PC12 cells (19, 20), Neuro2A cells (20, 21),
SHSY5Y cells (20)), and in a dopaminergic cell line (22). It is
considered that JNK-stimulated phosphorylation of the transcription
factor, c-Jun, represents an important step in the cascade of events
leading to apoptosis (23-25). The JNK signaling pathway is modulated
by JNK-interacting protein (JIP), which was originally identified as a
cytoplasmic inhibitor of JNK (26) and is now recognized as a scaffold
protein which, when overexpressed in cells, prevents translocation of
JNK to the nucleus and consequently inhibits JNK-mediated gene
expression (27). Significantly, the mouse homologue of JIP, islet brain 1 (IB1), has been shown to be highly expressed in hippocampus (28).
concentration, ROS accumulation, and JNK and p38
activation can be prevented by dietary manipulation with essential
fatty acids, for example the
-3 fatty acid, docosahexaenoic acid (7,
29). Here we investigate the possibility that its precursor,
eicosapentaenoic acid (EPA), which has been shown to have
anti-inflammatory properties (30, 31) and which inhibited the
age-related increase in IL-1
in hippocampus (32), might be effective
in protecting hippocampal neurons from damage induced by whole body
irradiation. We present evidence that indicates that hippocampal tissue
prepared from rats exposed to whole body irradiation exhibited
increases in ROS accumulation and JNK activation and that these changes
were coupled with evidence of apoptosis and with impairment in LTP. The
data indicate that treatment with EPA prevented these changes and
therefore acted as a neuroprotective and antiapoptotic agent.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-irradiated and
sham-irradiated rats treated with either diet. The resultant pellet was
resuspended in 1 ml of ice-cold 40 mM Tris buffer (pH 7.4),
and aliquots (1 ml) of homogenate were incubated with
2',7'-dichlorofluorescin diacetate (10 µl; final concentration 5 µM; from a stock solution of 500 µM in
methanol; Molecular Probes) at 37 °C for 15 min. To terminate the
reaction, the dye-loaded synaptosomes were centrifuged at 13,000 × g for 8 min. The pellet was resuspended in 1.5 ml of
ice-cold 40 mM Tris buffer (pH 7.4), and fluorescence was
monitored at a constant temperature of 37 °C at 488 nm excitation
(bandwidth 5 nm) and 525 nm emission (bandwidth 20 nm). Reactive oxygen
species formation was quantified from a standard curve of
2',7-dichlorofluorescein in methanol (range 0.05 to 1 µM). Results were expressed as nmol/mg tissue corrected
for protein.
-mercaptoethanol, 5%; bromphenol blue, 0.05% w/v), boiled for 5 min, and loaded onto
gels (10% SDS for PARP, c-Jun, and JIP and 12% for JNK). In the case
of cytochrome c, the cytosolic fraction was prepared by
homogenizing slices of hippocampus in lysis buffer and incubating for
20 min on ice and centrifuging (15,000 × g for 10 min
at 4 °C). The supernatant (i.e. cytosolic fraction) was
suspended in sample buffer to a final concentration of 300 µg/ml,
boiled for 3 min, and loaded (6 µg/lane) onto 12% gels. In all cases
proteins were separated by application of 30 mA constant current for
25-30 min, transferred onto nitrocellulose strips (225 mA for 75 min), and immunoblotted with the appropriate antibody. To assess JNK activity, proteins were immunoblotted with an antibody that
specifically targets phosphorylated JNK (1:300 in Tris-buffered
saline/Tween (0.05% Tween 20) containing 0.1% bovine serum albumin;
Santa Cruz Biotechnology) for 2 h at room temperature. To assess
cleavage of PARP, we immunoblotted with an antibody (1:500 in
phosphate-buffered saline (PBS)/Tween (0.1% Tween 20) containing 2%
non-fat dried milk) raised against the epitope corresponding to amino
acids 764-1014 of PARP of human origin (Santa Cruz Biotechnology
Inc.). To assess cytochrome c, a rabbit polyclonal antibody
(1:250 in PBS/Tween containing 2% non-fat dried milk; Santa Cruz
Biotechnology) raised against recombinant protein corresponding to
amino acids 1-104 of cytochrome c was used. In the case of
JIP-1, we immunoblotted with a goat polyclonal antibody (1:1000 in
Tris-buffered saline/Tween containing 0.1% bovine serum albumin; Santa
Cruz Biotechnology) raised against a peptide mapped at the carboxyl
terminus of JIP-1 of mouse origin for 2 h. To assess
phosphorylation of c-Jun, a mouse monoclonal antibody (1:200 in
PBS/Tween containing 2% non-fat dried milk; Santa Cruz Biotechnology)
raised against a peptide corresponding to amino acids 56-69 of c-Jun
of human origin was used. Immunoreactive bands were detected as
follows: peroxidase-conjugated anti-mouse IgG (Sigma) and SuperSignal
chemiluminescence (Pierce) for JNK and c-Jun, peroxidase-conjugated
anti-rabbit IgG (Sigma) and SuperSignal (Pierce) for PARP,
peroxidase-conjugated anti-rabbit IgG (Sigma) and ECL (Amersham
Biosciences) for cytochrome c and peroxide-labeled anti-goat
IgG (Vector Laboratories) and SuperSignal (Pierce) for JIP. All
immunoblots were exposed to film and processed using a Fuji x-ray
processor. Bands were quantified using densitometry (ZERO-Dscan Image
Analysis System, Scanalytics, Inc.).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (17K):
[in a new window]
Fig. 1.
Tetanic stimulation led to induction and
maintenance of LTP in both groups of sham-irradiated rats. Whereas
LTP was markedly attenuated in irradiated rats that received control
treatment, rats that were treated with EPA successfully expressed LTP.
Values are expressed as the mean percentage change in excitatory
postsynaptic potential (Epsp) slope (± S.E.;
n = 5 or 6) relative to the slope in the 5 min
preceding tetanic stimulation.

View larger version (27K):
[in a new window]
Fig. 2.
Mean values for ROS production
(a), JNK activation (b), and c-Jun
phosphorylation (c) were similar in control- and
EPA-treated sham-irradiated rats (compare lanes 1 and
2 in (b and c)). Irradiation
significantly increased these measures in control-treated rats
(p < 0.05; ANOVA; n = 6; see
lane 3 in b and c), but the
stimulatory effect was attenuated in EPA-treated rats (lane
4 in b and c) so that values were similar to those
observed in sham-irradiated rats. d, JIP-1 expression was
similar in hippocampal tissue prepared from both groups of
sham-irradiated rats (compare lanes 1 and 2) and
the control-treated irradiated group (lane 3) but was
significantly enhanced in tissue prepared from EPA-treated irradiated
rats (p < 0.05; ANOVA; n = 6; see
lane 4).
The irradiation-stimulated changes in ROS accumulation were mirrored by the changes in JNK activation. Thus JNK activation was similar in hippocampal tissue prepared from control-treated and EPA-treated sham-irradiated rats (Fig. 2b), and although it was significantly increased in tissue prepared from control-treated, irradiated rats (p < 0.05; ANOVA), this increase in JNK activation was prevented in EPA-treated rats. The sample immunoblot illustrates the irradiation-induced increase in JNK activation (lane 3) compared with the tissue prepared from the EPA-treated irradiated (lane 4) or sham-irradiated (lane 2) rats or from control-treated sham-irradiated rats (lane 1). JNK activation has been shown to trigger phosphorylation of c-Jun in a number of cell types, and therefore it was predicted that it would induce a similar change in hippocampus. Fig. 2c shows one sample immunoblot that indicates that c-Jun phosphorylation was enhanced in hippocampal tissue prepared from control-treated irradiated rats (lane 3) compared with tissue prepared from rats in the other treatment groups. Assessments of the mean data obtained from densitometric analysis revealed that the increase in c-Jun phosphorylation induced by irradiation in control-treated rats was significantly different from the mean value in the sham-irradiated control group (p < 0.05; ANOVA). Treatment with EPA suppressed the irradiation-induced increase in c-Jun phosphorylation.
Phosphorylation of c-Jun by JNK has been shown to be modified by JIP, and the current data indicate that although expression of JIP was similar in hippocampal tissue prepared from both sham-irradiated groups of rats (see lanes 1-3; Fig. 2d), it was markedly enhanced in hippocampal tissue prepared from irradiated rats that were treated with EPA (lane 4; Fig. 2d; p < 0.05; ANOVA compared with the mean values in any of the other three groups).
Cytochrome c translocation was examined by investigating
expression of the protein in the cytosol (Fig.
3a). The data indicate that
there was an irradiation-induced increase in cytochrome c translocation (compare lane 3 with each of the other lanes),
and analysis of mean data indicates that this increase was
significantly different from that in any of the other groups
(p < 0.01; ANOVA). Caspase-3 activation is one
consequence of an increase in cytochrome c expression in
cytosol, and the data presented in Fig. 3b indicate that
activity of caspase-3 paralleled the changes in cytochrome c. Thus enzyme activity was similar in both treatment groups
of sham-irradiated rats, but significantly enhanced in hippocampal tissue prepared from control-treated irradiated rats (p < 0.05; ANOVA). EPA treatment prevented the irradiation-induced
increase so that mean caspase-3 activity was similar in this group and the sham-irradiated groups of rats.
|
PARP cleavage was increased with irradiation as reflected by the
decreased expression of the 116-kDa fragment of the protein (Fig.
4a); this decrease is
illustrated in the sample immunoblot (lane 3) and is
reflected in the mean data obtained from densitometric analysis, which
revealed that the irradiated induced increase in PARP cleavage was
significantly different from that in hippocampal tissue prepared from
control-treated (lane 1) or EPA-treated (lane 2)
sham-irradiated rats (p < 0.01; ANOVA). EPA treatment
suppressed the irradiation-induced change (lane 4).
|
Cytospun cells prepared from hippocampus of each of the treatment groups were assessed for TUNEL staining. Fig. 4b indicates that the percentage of TUNEL-positive cells relative to the control was significantly greater in hippocampal preparations obtained from control-treated irradiated rats compared with sham-irradiated rats (p < 0.001; ANOVA); EPA treatment prevented this change.
The data are consistent with the idea that the increase in ROS
accumulation stimulated by irradiation triggered the cascade of
cellular events leading to cell death, and the effect was mediated by
JNK phosphorylation. Fig. 5a
indicates that H2O2 increased JNK activation
(p < 0.05; ANOVA) and that VIP, which has been shown
to inhibit JNK activation in certain cells, also abrogated H2O2 induced JNK activation in hippocampus.
Fig. 5b shows that H2O2 increased
caspase-3 activity in hippocampus (p < 0.05; ANOVA) and that inhibition of JNK by VIP prevented this effect, suggesting that increased ROS accumulation by stimulating JNK can lead to cell
death. It seems reasonable to propose that the impairment in LTP is a
consequence of the irradiation-induced cell death in hippocampus and
that the key event that leads to cell death is ROS accumulation.
|
| |
DISCUSSION |
|---|
|
|
|---|
We set out (a) to establish the effects of irradiation on LTP in perforant path-granule cell synapses in vivo, (b) to identify the cellular events stimulated by exposure to irradiation that might underlie the impairment in LTP, and (c) to assess the effectiveness of EPA treatment in reversing irradiation-induced changes.
We report that both the early and later responses of perforant path-granule cell synapses to tetanic stimulation were markedly attenuated in rats that were exposed to irradiation, supporting the previous finding that irradiation inhibits LTP in guinea pig CA1 in vitro (10-12). Significantly prior treatment with EPA prevented the inhibitory effect of irradiation on LTP; thus EPA-treated rats sustained LTP in a manner that was similar to the sham-irradiated cohort.
In an effort to identify the mechanism by which EPA might
exert its beneficial effects, we assessed ROS accumulation in
hippocampal tissue prepared from the same rats in which LTP analysis
was performed, because ROS accumulation has been shown previously to
increase following irradiation (37) and because LTP is impaired when ROS accumulation is increased (6, 15, 38, 39). We found that, in
parallel with the impairment in LTP, ROS accumulation was significantly
enhanced in hippocampal tissue prepared from irradiated rats that did
not receive EPA. Data have consistently suggested that an increase in
ROS is associated with an attenuation of LTP. For example,
H2O2 inhibits LTP in dentate gyrus in
vivo (14) and in CA1 in vitro (13). Indeed a negative
correlation between ROS concentration in hippocampus and ability of
rats to sustain LTP has been described (39). Moreover, overexpression of superoxide dismutase, which leads to formation of
H2O2, is associated with impaired LTP in CA1
in vitro, and LTP is restored in slices prepared from these
transgenic mice by addition of catalase (40), which metabolizes
H2O2 to O2 and H2O. The
mechanism by which irradiation leads to an increase in ROS is not
known; however, it has been shown that exposure of thymocytes to
irradiation leads to metabolism of arachidonic acid by lipoxygenase
(41), and this action can lead to the generation of ROS. It has also
been reported that irradiation increases generation of eicosanoids (42)
including prostaglandin E2 (42, 43), which is produced by
the action of cyclooxygenase on arachidonic acid. The role of
eicosanoids in the inflammatory response is well documented (44), and
therefore these findings are consistent with the idea that irradiation
induces inflammation. There are multiple possible ways in which EPA may
act, some of them being related to its known anti-inflammatory actions
(30, 31). At the molecular level, the effect might be related to
inhibition of phospholipases such as phospholipase A2 (45),
inhibition of cyclooxygenases and lipoxygenases (46), reduction of
pro-inflammatory cytokine synthesis (47, 48), activation of PPAR
receptors (49-51), or inhibition of transcription factor synthesis
(52). In addition to this, radiation damages membranes by destroying
their polyunsaturated fatty acid components, and the EPA may act in
part by providing a substrate for membrane repair (53). Recent data
from this laboratory indicated that the age-related decrease in LTP,
which was accompanied by an increase in ROS accumulation, was also
reversed by EPA treatment (32). In that case, the failure of rats to sustain LTP was also associated with an increase in hippocampal concentration of IL-1
. The finding that EPA treatment suppressed the
age-related increase in IL-1
concentration is further evidence of
its anti-inflammatory effect and supports previous results obtained in
other tissues (see Ref. 54).
Activation of JNK was markedly increased in hippocampal tissue prepared from rats exposed to irradiation, coupling this effect with the increase in ROS accumulation and the decrease in LTP. Both irradiation (16-18) and ROS (55-57) enhance JNK activation in a variety of cells; here we demonstrate that the H2O2-induced increase in JNK activation in hippocampus was attenuated by the nonspecific JNK inhibitor (58) VIP. Consistent with the idea that the primary action of EPA treatment is to inhibit the increase in ROS accumulation stimulated by irradiation is the observation that the downstream increase in JNK activation is also suppressed by EPA treatment. The pattern of activation of the transcription factor, c-Jun, exactly mirrored that of JNK activation in the different treatment groups providing support for the idea that they are activated in tandem by irradiation and protected from activation by EPA. It is of interest that EPA increased JIP expression in hippocampal tissue prepared from rats exposed to irradiation (but not sham-irradiated rats); the mechanism underlying this effect was not probed in this study, but this change represents one factor that may contribute to the inhibitory effect of EPA on c-Jun activation. It is possible that this effect of EPA contributes to its anti-inflammatory actions.
One relatively early event in apoptosis is disruption of the
mitochondrial transmembrane potential that is associated with cytochrome c translocation from mitochondria to cytosol
(59). The finding that cytochrome c translocation is
increased in hippocampal tissue prepared from rats that were exposed to
-irradiation suggests that irradiation induces mitochondrial
dysfunction. It is likely that this is a consequence of the
irradiation-induced increase in ROS because in vitro
analysis revealed that exposure of tissue to
H2O2 increased cytochrome c
translocation (32). This finding is supported by previous data which
indicated that H2O2 increased cytochrome
c translocation in Jurkat T cells within 2 h of
treatment (60), and both observations are consistent with the finding that oxidative stress disrupts mitochondrial transmembrane potential (59).
It has been suggested that cytochrome c translocation triggers a cascade of reactions characterized by caspase activation (61-62), and a key element of this cascade is the interaction of cytochrome c with apoptotic protease-activating factor-1 leading to the activation of caspase-9 (63). One of the consequences of this sequence of events is an increase in activation of caspase-3 (64, 65). Indeed activation of caspase-3 is considered to be a reliable marker of apoptosis, and the finding that apoptosis was induced following injection of active cytochrome c into cells pinpoints a key role for cytochrome c translocation in the process (66).
It seems likely that cytosolic cytochrome c results in activation of caspase-3 in hippocampus as well as in other tissues (67, 68), because we observed that irradiation induced parallel changes in both measures and that EPA treatment reversed the irradiation-induced changes in both cytochrome c translocation and caspase-3 activation. The data suggest that the increase in caspase-3 activity that occurred in hippocampal tissue prepared from irradiated rats was a consequence of the primary irradiation-stimulated increase in ROS accumulation because enzyme activity was increased in vitro by incubation in the presence of H2O2. VIP, which blocked H2O2-induced increase in JNK, also inhibited the H2O2-induced increase in caspase-3 activity indicating that the stimulatory effect of ROS on caspase-3 was dependent on JNK activation. These data can reasonably be interpreted as evidence that JNK activation plays a role in inducing apoptosis in hippocampus; findings that favor this hypothesis have been presented previously in several cell types. It is significant that EPA administration that led to increased JIP expression was accompanied by an attenuation in the irradiation-induced activation of JNK and the subsequent apoptosis. The mitochondrial protein, Bcl-2, is one substrate for JNK, and it has been shown that phosphorylation of this protein, which plays a role in maintenance of mitochondrial membrane integrity (and therefore prevents translocation of mitochondrial enzymes like cytochrome c), results in its inactivation (69, 70). This represents one mechanism by which JNK activation might lead to apoptosis.
One substrate for caspase-3 is the DNA repair enzyme PARP which, when cleaved, loses its ability to affect repair, and therefore PARP cleavage has also been considered to be a reliable indicator of apoptosis (71, 72). We found that PARP cleavage was increased by irradiation but that EPA treatment prevented this effect, probably as a consequence of the upstream effects of the treatment. In parallel with the irradiation-induced increase in PARP cleavage and consistent with the idea that it is an indicator of apoptosis is the finding that TUNEL staining, which is indicative of nicked DNA (a consequence of decreased DNA repair), was enhanced in hippocampal cells prepared from irradiated, compared with sham-irradiated, rats. Evidence from a number of earlier studies has indicated that irradiation induces apoptosis, for example in B lymphocytes (73), whereas it results in marked cell loss in hippocampus (74). EPA treatment inhibited the irradiation-induced increase in TUNEL staining; it is proposed that this action of EPA stems from its ability to prevent the irradiation-induced increase in ROS accumulation.
The data demonstrate that irradiation induces a cascade of events in
hippocampus which ultimately leads to cell death; a pivotal element in
this cascade is activation of JNK induced by ROS accumulation. It is
likely that apoptosis leads to a deterioration in several functions; in
this study we assessed the effect on LTP and found that it was markedly
impaired by irradiation. A particularly significant finding of the
present study is that EPA treatment prevented the irradiation-induced
impairment in LTP. The data are consistent with the idea that this
results from its ability to suppress the increase in ROS accumulation
and the subsequent indicators of apoptosis that are induced by irradiation.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 353-1-6081770; Fax: 353-1-6793545; E-mail: lynchma@tcd.ie.
Published, JBC Papers in Press, March 23, 2002, DOI 10.1074/jbc.M202387200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
ROS, reactive oxygen
species;
JNK, c-Jun NH2-terminal kinase;
LTP, long term
potentiation;
PARP, poly(ADP-ribose) polymerase;
TUNEL, terminal dUTP
nick-end labeling;
MAP, mitogen-activated protein;
IL-1
, interleukin-1
;
JIP, JNK-interacting protein;
EPA, eicosapentaenoic
acid;
PBS, phosphate-buffered saline;
ANOVA, analysis of variance;
VIP, vasoactive intestinal peptide.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Halliwell, B. (1992) J. Neurochem. 59, 1609-1623[Medline] [Order article via Infotrieve] |
| 2. | Benkovic, S. A., and Connor, J. R. (1993) J. Comp. Neurol. 338, 97-113[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Rice-Evans, C., and Burdon, R. (1993) Prog. Lipid Res. 32, 71-110[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Jenner, J. P., Daniel, S. E., Lees, A. J., Marsden, D. C., and Halliwell, B. (1998) J. Neurochem. 71, 2112-2122[Medline] [Order article via Infotrieve] |
| 5. |
Smith, M. A.,
Sayre, L. M.,
Anderson, V. E.,
Harris, P. L.,
Beal, M. F.,
Kowall, N.,
and Perry, G.
(1998)
J. Histochem. Cytochem.
46,
731-735 |
| 6. |
Murray, C.,
and Lynch, M. A.
(1998)
J. Biol. Chem.
273,
12161-12168 |
| 7. | O'Donnell, E., Vereker, E., and Lynch, M. A. (2000) Eur. J. Neurosci. 12, 345-352[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Vereker, E.,
O'Donnell, E.,
and Lynch, M. A.
(2000)
J. Neurosci.
20,
6811-6819 |
| 9. | Riley, P. A. (1994) Int. J. Radiat. Biol. 65, 27-33[Medline] [Order article via Infotrieve] |
| 10. | Tolliver, J. M., and Pellmar, T. C. (1987) Radiat. Res. 112, 555-563[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Pellmar, T. C., Schauer, D. A., and Zeman, G. H. (1990) Radiat. Res. 122, 209-214[Medline] [Order article via Infotrieve] |
| 12. | Pellmar, T. C., and Lepinski, D. L. (1993) Radiat. Res. 136, 255-261[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Pellmar, T. C., Hollinden, G. E., and Sarvey, J. M. (1991) Neuroscience 44, 353-359[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Vereker, E., O'Donnell, E., Lynch, A. M., Kelly, Á., Nolan, Y., and Lynch, M. A. (2001) Eur. J. Neurosci. 14, 1809-1819[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Murray, C.,
and Lynch, M. A.
(1998)
J. Neurosci.
18,
2974-2981 |
| 16. |
Chen, Y.-R.,
Meyer, C. F.,
and Tan, T.-H.
(1996)
J. Biol. Chem.
271,
631-634 |
| 17. | Zanke, B. W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L. A., Zon, L., Kyriakis, J., Liu, F.-F., and Woodgett, J. R. (1996) Curr. Biol. 6, 606-613[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Chen, Y.-R.,
Wang, X.,
Templeton, D.,
Davis, R. J.,
and Tan, T.-H.
(1996)
J. Biol. Chem.
271,
31929-31936 |
| 19. |
Xia, Z.,
Dickens, M.,
Raingeaud, J.,
Davis, R. J.,
and Greenberg, M. E.
(1995)
Science
270,
1326-1331 |
| 20. | Mielke, K., and Herdegen, T. (2000) Prog. Neurobiol. 61, 45-60[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Kumagae, Y., Zhang, Y., Kim, O. J., and Miller, C. A. (1999) Mol. Brain Res. 67, 10-17[Medline] [Order article via Infotrieve] |
| 22. | Choi, W. S., Yoon, S. Y., Oh, T. H., Choi, E. J., O'Malley, K. L., and Oh, Y. J. (1999) J. Neurosci. Res. 57, 86-94[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Neary, J. T.
(1997)
News Physiol. Sci.
12,
286-293 |
| 24. | Ip, Y. T., and Davis, R. J. (1998) Curr. Opin. Cell. Biol. 10, 205-219[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Harper, S. J., and LoGrasso, P. (2001) Cell. Signal. 13, 299-310[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Dickens, M.,
Rogers, J. S.,
Cavanagh, J.,
Raitano, A.,
Xia, Z.,
Halpern, J. R.,
Greenberg, M. E.,
Sawyers, C. L.,
and Davis, R. J.
(1997)
Science
277,
693-696 |
| 27. |
Whitmarsh, A. J.,
Cavanagh, J.,
Tournier, C.,
Yasuda, J.,
and Davis, R. J.
(1998)
Science
281,
1671-1674 |
| 28. | Pettel, J.-B., Heafliger, J.-A., Stable, J. K., Widmann, C., Welker, E., Hirling, H., Bonny, C., Nicod, P., Catsicas, S., Waeber, G., and Reiderer, B. M. (2000) Eur. J. Neurosci. 12, 621-632[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | McGahon, B. M., Murray, C. A., Horrobin, D. F., and Lynch, M. A. (1999) Neurobiol. Aging 20, 643-653[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Hayashi, H., Tanaka, Y., Hibino, H., Umeda, Y., Kawamitsu, H., Fujimoto, H., and Amakawa, T. (1999) Curr. Med. Res. Opin. 15, 177-184[Medline] [Order article via Infotrieve] |
| 31. | Babcock, T., Helton, W. S., and Espat, N. J. (2000) Nutrition 16, 1116-1118[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Martin, D. S. D., Spencer, P., Horrobin, D., and Lynch, M. A. (2000) Soc. Neurosci. 26, 889 (abstr.) |
| 33. | McGahon, B. M., Martin, D. S. D., Horrobin, D. F., and Lynch, M. A. (1999) Neuroscience 94, 305-314[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Lebel, C. P., and Bondy, S. C. (1990) Neurochem. Int. 17, 435-440[CrossRef] |
| 35. |
Vereker, E.,
Campbell, V.,
Roche, E.,
McEntee, E.,
and Lynch, M. A.
(2000)
J. Biol. Chem.
275,
26252-26528 |
| 36. |
MacManus, A.,
Ramsden, M.,
Murray, M.,
Pearson, H. A.,
and Campbell, V.
(2000)
J. Biol. Chem.
275,
4713-4718 |
| 37. | Yuen, K. S., and Halliday, G. M. (1997) Photochem. Photobiol. 65, 587-592[Medline] [Order article via Infotrieve] |
| 38. | Lynch, M. A. (1998) Prog. Neurobiol. 56, 1-19[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Lynch, M. A. (2002) Vitam. Horm. 64, 185-219[Medline] [Order article via Infotrieve] |
| 40. | Gahtan, E., Auerbach, J. M., Groner, Y., and Segal, M. (1998) Eur. J. Neurosci. 10, 538-544[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Korystov, Y. N., Dobrovinskaya, O. R., Shaposhnikova, V. V., and Eidus, L. K. (1996) FEBS Lett. 388, 238-241[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Steinhauerr, K. K., Gibbs, I., Ning, S., French, J. N., Armstrong, J., and Knox, S. J. (2000) Int. J. Radiat. Oncol. Biol. Phys. 48, 325-328[Medline] [Order article via Infotrieve] |
| 43. | Michalowski, A. S. (1994) Acta Oncol. 33, 139-157[Medline] [Order article via Infotrieve] |
| 44. |
Obukowicz, M. G.,
Welsch, D. J.,
Salsgiver, W. J.,
Martin-Berger, C. L.,
Chinn, K. S.,
Duffin, K. L.,
Raz, A.,
and Needleman, P.
(1998)
J. Pharmacol. Exp. Ther.
287,
157-166 |
| 45. | Finnen, M. J., and Lovell, C. R. (1991) Biochem. Soc. Trans. 19, 91 (abstr.) |
| 46. |
Needleman, P.,
Raz, A.,
Minkes, M. S.,
Ferrendelli, J. A.,
and Sprecher, H.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
944-949 |
| 47. | Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W., Cannon, J. G., Rogers, T. S., Klempner, M. S., and Weber, P. C. (1989) N. Engl. J. Med. 320, 265-271[Abstract] |
| 48. | Purasiri, P., Murray, A., Richardson, S., Heys, S. D., Horrobin, D., and Eremin, O. (1994) Clin. Sci. 87, 711-717[Medline] [Order article via Infotrieve] |
| 49. |
Kliewer, S. A.,
Sundseth, S. S.,
Jones, S. A.,
Brown, P. J.,
Wisely, G. B.,
Koble, C. S.,
Devchand, P.,
Wahli, W.,
Willson, T. M.,
Lenhard, J. M.,
and Lehmann, J. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4318-4323 |
| 50. |
Forman, B. M.,
Chen, J.,
and Evans, R. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4312-4317 |
| 51. | Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., Kliewer, S. A., and Milburn, M. V. (1999) Mol. Cell 3, 397-403[CrossRef][Medline] [Order article via Infotrieve] |
| 52. |
Palakurthi, S. S.,
Fluckiger, R.,
Aktas, H.,
Changolkar, A. K.,
Shahsafaei, A.,
Harneit, S.,
Kilic, E.,
and Halperin, J. A.
(2000)
Cancer Res.
60,
2919-2925 |
| 53. | Horrobin, D. F. (1991) Med. Hypotheses 35, 23-26[CrossRef][Medline] [Order article via Infotrieve] |
| 54. |
Dinarello, C. A.
(1996)
Blood
87,
2095-2147 |
| 55. |
Lo, Y. Y. C.,
Wong, J. M. S.,
and Cruz, T. F.
(1996)
J. Biol. Chem.
271,
15703-15707 |
| 56. | Tournier, C., Thomas, G., Pierre, J., Jacquemin, C., Pierre, M., and Saunier, B. (1997) Eur. J. Biochem. 244, 587-595[Medline] [Order article via Infotrieve] |
| 57. | Wang, X., Martindale, J. L., Liu, Y., and Holbrook, N. J. (1998) Biochem. J. 333, 291-300 |
| 58. | Delgado, M., and Ganea, D. (2000) J. Neuroimmunol. 110, 97-105[CrossRef][Medline] [Order article via Infotrieve] |
| 59. | Cortopassi, G. A., and Wong, A. (1999) Biochim. Biophys. Acta 1410, 183-193[Medline] [Order article via Infotrieve] |
| 60. | Stridh, H., Kimland, M., Jones, S. P., Orrenius, S., and Hampton, M. B. (1998) FEBS Lett. 429, 351-355[CrossRef][Medline] [Order article via Infotrieve] |
| 61. | Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, W. (1996) Cell 86, 147-157[CrossRef][Medline] [Order article via Infotrieve] |
| 62. | Rossé, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B., and Borner, C. (1998) Nature 391, 496-499[CrossRef][Medline] [Order article via Infotrieve] |
| 63. |
Green, D. R.,
and Reed, J. C.
(1998)
Science
281,
1309-1312 |
| 64. | Kannan, K., and Jain, S. K. (2000) Pathophysiology 7, 153-163[CrossRef][Medline] [Order article via Infotrieve] |
| 65. | Slee, E. A., Adrain, C., and Martin, S. J. (1999) Cell Death Differ. 6, 1067-1074[CrossRef][Medline] [Order article via Infotrieve] |
| 66. | Zhivotovsky, B., Hanson, K. P., and Orrenius, S. (1998) Cell Death Differ. 5, 459-460[CrossRef][Medline] [Order article via Infotrieve] |
| 67. |
Kluck, R. M.,
Bossy-Wetzel, E.,
Green, D. R.,
and Newmeyer, D. D.
(1997)
Science
275,
1132-1136 |
| 68. |
Yang, J.,
Liu, X.,
Bhalla, K.,
Kim, C. N.,
Ibrado, A. M.,
Cai, J.,
Peng, T.-I.,
Jones, D. P.,
and Wang, X.
(1997)
Science
275,
1129-1136 |
| 69. |
Park, J.,
Kim, I., Oh, Y. J.,
Lee, K.,
Han, P. L.,
and Choi, E. J.
(1997)
J. Biol. Chem.
272,
16725-16728 |
| 70. |
Maundrell, K.,
Antonsson, B.,
Magnenat, E.,
Camps, M.,
Muda, M.,
Chabert, C.,
Gillieron, C.,
Boschert, U.,
Vial-Knecht, E.,
Martinou, J. C.,
and Arkinstall, S.
(1997)
J. Biol. Chem.
272,
25238-25242 |
| 71. | Martinou, J. C., and Sadoul, R. (1996) Curr. Opin. Neurobiol. 6, 609-614[CrossRef][Medline] [Order article via Infotrieve] |
| 72. | O'Brien, M. A., Moravec, R. A., and Riss, T. L. (2001) BioTechniques 30, 886-891[Medline] [Order article via Infotrieve] |
| 73. | Hallan, E., Blomhoff, H. K., Smeland, E. B., and Lomo, J. (1997) Scand. J. Immunol. 46, 601-608[CrossRef][Medline] [Order article via Infotrieve] |
| 74. | Czéh, B., Seress, L., and Czéh, G. (1998) Hippocampus 8, 548-561[CrossRef][Medline] [Order article via Infotrieve] |